Question 1
When and why should patients with T2D have their UACR tested?
Navdeep Tangri, MD PhD, FRCPC
Question 3
What are the key differences between steroidal MRAs and nonsteroidal MRAs?
Daniel Ngui, BScPT, PT, MD, CCFP, FCFP
Question 4
For which patients should novel nonsteroidal MRAs be considered?
Normand Proulx, MD, FRCP(C)
Question 5
What data supports the use of novel nonsteroidal MRAs in patients already on an SGLT2 inhibitor?
Normand Proulx, MD, FRCP(C)
No articles created yet
